What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
His primary areas of study are Nuclear medicine, Positron emission tomography, Radiology, PET-CT and Prostate cancer.
His Nuclear medicine study integrates concerns from other disciplines, such as Cancer, Biopsy, Somatostatin receptor, Prospective cohort study and Multiple myeloma.
His Positron emission tomography study incorporates themes from Neuroendocrine tumors, Tomography, Magnetic resonance imaging and Lymphoma.
His Fdg pet ct and Scintigraphy study in the realm of Radiology connects with subjects such as In patient.
His PET-CT study combines topics from a wide range of disciplines, such as Guideline, Pathology, DOTA, Stage and Radiation therapy.
His Prostate cancer study deals with Retrospective cohort study intersecting with Androgen deprivation therapy and Oncology.
His most cited work include:
- Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy (368 citations)
- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 (333 citations)
- Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation (314 citations)
What are the main themes of his work throughout his whole career to date?
Stefano Fanti mainly focuses on Radiology, Nuclear medicine, Positron emission tomography, PET-CT and Internal medicine.
His work in Radiology is not limited to one particular discipline; it also encompasses Prostate cancer.
His research integrates issues of Radiation therapy and Urology in his study of Prostate cancer.
His Nuclear medicine research integrates issues from Computed tomography, Prospective cohort study and Multiple myeloma.
His biological study spans a wide range of topics, including Cancer, Lymphoma, Retrospective cohort study, Pathology and Magnetic resonance imaging.
The various areas that he examines in his Internal medicine study include Gastroenterology, Surgery, Oncology and Cardiology.
He most often published in these fields:
- Radiology (39.32%)
- Nuclear medicine (31.17%)
- Positron emission tomography (26.92%)
What were the highlights of his more recent work (between 2017-2021)?
- Prostate cancer (21.25%)
- Radiology (39.32%)
- Internal medicine (22.08%)
In recent papers he was focusing on the following fields of study:
Stefano Fanti spends much of his time researching Prostate cancer, Radiology, Internal medicine, PET-CT and Oncology.
His study in Prostate cancer is interdisciplinary in nature, drawing from both Positron emission tomography, Radiation therapy, Molecular imaging and Urology.
Stefano Fanti combines subjects such as Cancer, Magnetic resonance imaging, Glutamate carboxypeptidase II, Stage and Computed tomography with his study of Positron emission tomography.
His study in the field of Fdg pet ct and Biopsy is also linked to topics like In patient.
Stefano Fanti focuses mostly in the field of Internal medicine, narrowing it down to topics relating to MEDLINE and, in certain cases, Medical physics.
His PET-CT study is focused on Nuclear medicine in general.
Between 2017 and 2021, his most popular works were:
- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 (333 citations)
- Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019[Formula presented] (88 citations)
- Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review (81 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
The scientist’s investigation covers issues in Prostate cancer, Internal medicine, Oncology, Positron emission tomography and Biochemical recurrence.
His Prostate cancer research is multidisciplinary, incorporating perspectives in Guideline, PET-CT, Radiation therapy and Disease.
His PET-CT research entails a greater understanding of Radiology.
His work in the fields of Internal medicine, such as Concomitant, overlaps with other areas such as Hormone refractory prostate cancer.
His Positron emission tomography research is under the purview of Nuclear medicine.
His Nuclear medicine study combines topics in areas such as Resection and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
